ArticleDrug design, development and therapy2016

In vitro and in vivo efficacy of afatinib as a single agent or in combination with gemcitabine for the treatment of nasopharyngeal carcinoma.

Cong Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.